Search Results 71-80 of 15750 for alt

  1. Biliary atresia - Diagnosis and treatment - Mayo Clinic

    Mildly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which are liver enzymes. Matrix metalloproteinase-7 (MMP7) testing.

  2. Publications - Mithri Junna, M.D. - Mayo Clinic

    Chang JL, Goldberg AN, Alt JA, Mohammed A, Ashbrook L, Auckley D, Ayappa I, Bakhtiar H, Barrera JE, Bartley BL, Billings ME, Boon MS, Bosschieter P ...

  3. A Study To Evaluate At Home Administration Of Pertuzumab Combined With Trastuzumab To Treat Patients With HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

    ... (ALT) levels as defined below: Patients with early breast cancer: AST and ALT > 1.5 x ULN;; Patients with metastatic breast cancer: AST and ALT > 2.5 x ULN; ...

  4. Liver transplant - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  5. Publications - Lilly H. Wagner, M.D. - Mayo Clinic

    ... Alt E. CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro. Cancer Lett. 2009 Jul 18; 280 (1):65-71 Epub 2009 Mar 14

  6. Evaluate The Safety, Tolerability, Pharmacokinetics And Efficacy Of BL-M05D1 In Subjects With Solid Tumors - Mayo Clinic

    ... (ALT) without liver metastasis ≤3.0×ULN, AST and ALT with liver metastasis ≤5.0×ULN NOTE: For patients with Gilbert's syndrome, conjugated bilirubin ≤1.5 ...

  7. An Extension Study To Assess The Safety Of The Use Of Cannabidiol In Children And Young Adults With Dravet Or Lennox-Gastaut Syndromes - Mayo Clinic

    Alanine aminotransferase [ALT] >5 x upper limit of normal [ULN] or total bilirubin [TBL] >2 x ULN; ALT or aspartate aminotransferase (AST) >3 x ULN and ...

  8. Neratinib +/- Fulvestrant In Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer - Mayo Clinic

    AST and ALT ≤3× ULN or < 5 ULN for patients with liver metastases. Able to understand and willing to sign an IRB approved written informed consent document ...

  9. A Study Of NST-6179 In Subjects With Intestinal Failure-Associated Liver Disease (IFALD). - Mayo Clinic

    ALT and AST \<5 × ULN; 2. Total bilirubin ≤2.5 mg/dL in the absence of Gilbert's Syndrome. 3. Serum albumin ≥2.5 g/dL; 4. International normalized ratio ...

  10. A Study To Evaluate The Effectiveness And Safety Of Benralizumab In Patients With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    ... ALT >5×ULN if documented HES with liver manifestations). Transient increase of AST/ALT level that resolves by the time of randomisation is acceptable if, in ...